- 3701. Brushing
- [The act of cleaning teeth with a brush to remove plaque and prevent tooth decay. ( NCI )] (UMLS (NCI) C0040461) =Therapeutic or Preventive Procedure ;
=preventive dentistry;
| - 3751. Bubo
- (UMLS (HL7) C1546567) =Intellectual Product =Specimen Source Codes;
|
- 3702. Brushing, Gastric
- (UMLS (HL7) C1546646) =Intellectual Product =Specimen Source Codes;
| - 3752. bucca
- [ ] (UMLS (CSP) C0007966) =Body Location or Region ;
=Body Part;
|
- 3703. Bruton's Sex-Linked Agammaglobulinemia
- [X-linked agammaglobulinemia. An immunodeficiency state characterized (usually) by profoundly low concentrations of serum immunoglobulins of all classes, although occasionally significant amounts of one or more isotypes can be found. The fundamental defect in XLA affects early lineage B cells. ( NCI )] (UMLS (NCI) C0221026) =Disease or Syndrome ;
| - 3753. Buccal
- (UMLS (HL7) C0442010) =Spatial Concept =Body Part;
|
- 3704. bruxism
- [oral habit involving involuntary rhythmic or spasmodic nonfunctional gnashing, grinding and clenching of teeth, usually during sleep. ( CSP )] (UMLS (CSP) C0006325) =Mental or Behavioral Dysfunction ;
=chewing;
Dental Disorder =Sleep Bruxism | - 3754. Buccal Artery
- (UMLS (NCI) C0226151) =Body Part, Organ, or Organ Component
|
- 3705. BRW1C
- [Encoded by human TSSC3 Gene, 152-amino acid 17 kD TSSC3 Protein is expressed in fetal and adult liver, lung, and kidney, placenta, and adult pancreas. With similarity to TDAG51, essential for FAS expression and susceptibility to apoptosis, TSSC3 may be involved in susceptibility to apoptosis. Mouse Tssc3 encodes a small cytoplasmic protein with a pleckstrin-homology (PH) domain. (from Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1336685) BWR1C;
HLDA2;
IPL;
PHLDA2;
TSSC3;
Tumor Suppressing Subtransferable Candidate 3 Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 3755. Buccal Cavity
- [oval shaped oral cavity located at the apex of the digestive tract. ( CSP )] (UMLS (NCI) C0226896) =Body Space or Junction =Body Part;
oral pharyngeal =lip;
mouth mucosa;
Lingual;
palate;
|
- 3706. BRYO/2-CdA
- (UMLS (NCI) C0677831) =Therapeutic or Preventive Procedure ;
| - 3756. Buccal Mucosa Neoplasm
- (UMLS (NCI) C0345563) =Neoplastic Process
|
- 3707. BRYO/CDDP
- (UMLS (NCI) C0677786) =Therapeutic or Preventive Procedure
| - 3757. Buccal Mucosa Papilloma
- (UMLS (NCI) C1332641) Papilloma of Buccal Mucosa;
Papilloma of the Buccal Mucosa;
=Neoplastic Process ;
|
- 3708. BRYO/FAMP
- (UMLS (NCI) C0678092) =Therapeutic or Preventive Procedure
| - 3758. Buccal Mucosa Squamous Cell Carcinoma
- (UMLS (NCI) C0280299) =Neoplastic Process
|
- 3709. BRYO/IL-2/IONO
- (UMLS (NCI) C0678048) =Therapeutic or Preventive Procedure ;
| - 3759. Buccal Mucosa Verrucous Carcinoma
- (UMLS (NCI) C0280307) =Neoplastic Process
|
- 3710. BRYO/VCR
- (UMLS (NCI) C0392994) =Therapeutic or Preventive Procedure
| - 3760. Buccal Salivary Gland
- (UMLS (NCI) C0930555) =Body Part, Organ, or Organ Component
|
- 3711. Bryophyta
- [A division of the plant kingdom. Bryophyta contains the subdivision, Musci, which contains the classes: Andreaeopsida, BRYOPSIDA, and SPHAGNOPSIDA. ( MSH )] (UMLS (CSP) C0282635) =Plant ;
| - 3761. BuccalMucosaRoute
- [Buccal mucosa ( HL7V3.0 )] (UMLS (HL7) C1698336) =Functional Concept ;
=RouteBySite;
=Topical application, buccal |
- 3712. bryostatin
- [natural product with antineoplastic activity; derived from the marine bryozoan Bugula neritana. ( CSP )] (UMLS (CSP) C0054173) =Organic Chemical; Pharmacologic Substance =[AN000] ANTINEOPLASTICS;
animal extract | - 3762. Buccinator
- (UMLS (NCI) C0224121) =Body Part, Organ, or Organ Component
|
- 3713. Bryostatin 1/Gemcitabine
- (UMLS (NCI) C0879371) =Therapeutic or Preventive Procedure
| - 3763. Bucconeural Duct
- [The slender tubular part of the hypophysial diverticulum; the stalk of Rathke's pocket. ( NCI )] (UMLS (NCI) C0229549) =Body Part, Organ, or Organ Component
|
- 3714. Bryostatin 1/Interleukin-2
- (UMLS (NCI) C0879287) =Therapeutic or Preventive Procedure
| - 3764. Bucket handle tear of lateral meniscus
- [ ] (UMLS (ICD9CM) C0434992) =Injury or Poisoning
|
- 3715. Bryostatin 1/Paclitaxel
- (UMLS (NCI) C0678003) =Therapeutic or Preventive Procedure
| - 3765. BUCLIZINE
- (UMLS (NCI) C0164386) =Organic Chemical; Pharmacologic Substance ;
=Piperazines;
[CN550] ANTIVERTIGO AGENTS =Buclizine Hydrochloride |
- 3716. Bryostatin 1/Sargramostim
- (UMLS (NCI) C0935803) =Therapeutic or Preventive Procedure
| - 3766. Buclizine Hydrochloride
- (UMLS (NCI) C0304304) =Organic Chemical; Pharmacologic Substance ;
=BUCLIZINE;
=BUCLIZINE HYDROCHLORIDE 50 MG |
- 3717. Bs
- [Supernumerary maxillary right first primary molar ( HL7V3.0 )] (UMLS (HL7) C1552147) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 3767. Budd-Chiari syndrome
- [A condition in which the hepatic venous outflow is obstructed anywhere from the small HEPATIC VEINS to the junction of the INFERIOR VENA CAVA and the RIGHT ATRIUM. Usually the blockage is extrahepatic and caused by blood clots (THROMBUS) or fibrous webs. Parenchymal FIBROSIS is uncommon. ( MSH )] (UMLS (ICD9CM) C0856761) =Disease or Syndrome
|
- 3718. BSO/L-PAM
- (UMLS (NCI) C0279762) =Therapeutic or Preventive Procedure
| - 3768. Buddhist
- [The teaching ascribed to Gautama Buddha (ca. 483 B.C.) holding that suffering is inherent in life and that one can escape it into nirvana by mental and moral self-purification. (Webster, 3d ed) ( MSH )] (UMLS (HL7) C0006343) =Idea or Concept ;
=religion;
|
- 3719. BSRL/CPTR
- (UMLS (NCI) C0279009) =Therapeutic or Preventive Procedure ;
| - 3769. Buddhist: Mahayana
- (UMLS (HL7) C1549414) =Idea or Concept =religion;
|
- 3720. BSRL/FLUT
- (UMLS (NCI) C0677834) =Therapeutic or Preventive Procedure ;
| - 3770. Buddhist: Other
- (UMLS (HL7) C1549415) =Idea or Concept =religion;
|
- 3721. BSRL/TMX
- (UMLS (NCI) C0278926) =Therapeutic or Preventive Procedure
| - 3771. Buddhist: Tantrayana
- (UMLS (HL7) C1549416) =Idea or Concept =religion;
|
- 3722. BTAF1
- [TAF172 is an SNF2/RAD54 helicase family member that regulates transcription in association with TBP. Transcription initiation by RNA polymerase II requires TBP and TAFs, in two complexes, TFIID and B-TFIID. TFIID is composed of TBP and many TAFs. The majority of TBP is present in B-TFIID, composed of TBP and TAF172, and has DNA-dependent ATPase activity. TAF172 harbors seven ATPase characteristic motifs and possesses DNA-dependent ATPase activity. The stable association of TBP and TAF172 requires DNA. TAF172 drives the dissociation of TBP from DNA, freeing the TBP to associate with other TATA boxes or TATA-less promoters. ( NCI )] (UMLS (NCI) C0671988) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 3772. Buddhist: Theravada
- (UMLS (HL7) C1549417) =Idea or Concept =religion;
|
- 3723. BTAF1
- [This gene is involved in transcription initiation and transcriptional regulation. ( NCI )] (UMLS (NCI) C1332452) BTAF1 Gene;
BTAF1 RNA Polymerase II, B-TFIID Transcription Factor-Associated, 170kDa (Mot1 Homolog, S. Cerevisiae) Gene;
=Gene or Genome ;
| - 3773. budding yeast
- [An order of fungi in the phylum Ascomycota that multiply by budding. They include the telomorphic ascomycetous yeasts which are found in a very wide range of habitats. ( MSH )] (UMLS (CSP) C0014181) =Fungus ;
|
- 3724. BTS 18,322
- (UMLS (NCI) C0700847) =Organic Chemical; Pharmacologic Substance
| - 3774. Budget
- [A summary of intended expenditures along with proposals for how to meet them; a sum of money allocated for a particular purpose. ( NCI )] (UMLS (NCI) C0006347) =Intellectual Product ;
|
- 3725. BTS 54524
- (UMLS (NCI) C0286000) =Organic Chemical; Pharmacologic Substance ;
| - 3775. Buena Vista Rancheria of Me-Wuk Indians of Califor
- (UMLS (HL7) C1554241) =Population Group =NativeEntityContiguous;
|
- 3726. BTS _ Blood product transfusion/disposition
- (UMLS (HL7) C1549267) =Health Care Activity =Event Type;
| - 3776. Buerger's disease
- [A non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities. It is characterized by occlusive THROMBOSIS and FIBROSIS in the vascular wall leading to digital and limb ISCHEMIA and ulcerations. Thromboangiitis obliterans is highly associated with tobacco smoking. ( MSH )] (UMLS (CSP) C0040021) =Disease or Syndrome =Arterial Occlusive Diseases;
angiitis |
- 3727. Btu (59 ![DEGREE SIGN]!F)
- [1.0548 kJ ( HL7V3.0 )] (UMLS (HL7) C1552631) Btu (59 ??F);
=Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 3777. bufadienolide
- [ ] (UMLS (CSP) C0256159) =Steroid
|
- 3728. Btu (60 ![DEGREE SIGN]!F)
- [1.05468 kJ ( HL7V3.0 )] (UMLS (HL7) C1552632) Btu (60 ??F);
=Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 3778. buffer
- [chemical system that functions to control the levels of specific ions in solution; when the level of hydrogen ion in solution is controlled the system is called a pH buffer. ( CSP )] (UMLS (CSP) C0006353) =Biologically Active Substance; Indicator, Reagent, or Diagnostic Aid =reagent/indicator;
|
- 3729. Btu (intl. table)
- [1.05505585262 kJ ( HL7V3.0 )] (UMLS (HL7) C1552975) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 3779. Buffered 10% formalin
- (UMLS (HL7) C1550052) =Organic Chemical; Biomedical or Dental Material =Additive/Preservative;
|
- 3730. Btu (mean)
- [1.05587 kJ ( HL7V3.0 )] (UMLS (HL7) C1552974) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 3780. Buffered 10% formalin
- [Formaldehyde 4% w/v; methyl alcohol 1% w/v; phosphate buffering salts. Tissue preservative ( HL7V3.0 )] (UMLS (HL7) C1561456) =Intellectual Product =MaterialEntityAdditive;
|
- 3731. Btu (thermochemical)
- [1.05435 kJ ( HL7V3.0 )] (UMLS (HL7) C1552976) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 3781. Buffered Citrate
- [3.8% Citrate buffered to a pH of 5.5 for Westergren Sedimentation Rate ( HL7V3.0 )] (UMLS (HL7) C1553427) =Intellectual Product =MaterialEntityAdditive;
|
- 3732. Btu (usual)
- [1 [Btu_th] ( HL7V3.0 )] (UMLS (HL7) C1552977) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 3782. Buffered Citrate (Westergren Sedimentation Rate)
- (UMLS (HL7) C1550095) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Additive/Preservative;
|
- 3733. BU/CPFX/CTX/PTX
- (UMLS (NCI) C0281474) =Therapeutic or Preventive Procedure
| - 3783. Buffered skim milk
- (UMLS (HL7) C1550055) =Organic Chemical; Biomedical or Dental Material =Additive/Preservative;
|
- 3734. BU/CPFX/L-PAM/PTX/TSPA
- (UMLS (NCI) C0281476) =Therapeutic or Preventive Procedure
| - 3784. Buffered skim milk
- [50% skim milk in 0.01 M phosphate-buffered saline. Maintain virus viability ( HL7V3.0 )] (UMLS (HL7) C1561457) =Intellectual Product =MaterialEntityAdditive;
|
- 3735. BU/CTX
- (UMLS (NCI) C0278611) =Therapeutic or Preventive Procedure
| - 3785. Buffy Coat Interleukin
- [A recombinant cytokine chemically identical to or similar to secreted signaling molecules secreted by leukocyte cells. Leukocyte interleukins are essential in many immune responses, such as antibodies production, modulating secretion of other cytokines, and activation of bone marrow stem cells. ( NCI )] (UMLS (NCI) C0392999) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 3736. BU/CTX/DAC
- (UMLS (NCI) C0393038) =Therapeutic or Preventive Procedure
| - 3786. Bufo
- [ ] (UMLS (CSP) C0006354) =Amphibian ;
|
- 3737. BU/CTX/DHAD
- (UMLS (NCI) C0281391) =Therapeutic or Preventive Procedure ;
| - 3787. bufotenine
- [A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a tool in CNS studies and misused as a psychedelic. ( MSH )] (UMLS (CSP) C0006360) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance; Hazardous or Poisonous Substance
|
- 3738. BU/CTX/IFN-A/ZDV
- (UMLS (NCI) C0338174) =Therapeutic or Preventive Procedure
| - 3788. Buggy Creek virus
- [ ] (UMLS (CSP) C0597805) =Virus
|
- 3739. BU/CTX/MePRDL
- (UMLS (NCI) C0678058) =Therapeutic or Preventive Procedure ;
| - 3789. Building
- (UMLS (HL7) C1547706) =Functional Concept ;
=HL7 Vocabulary Version 2.5;
|
- 3740. BU/CTX/TSPA
- (UMLS (NCI) C0281597) =Therapeutic or Preventive Procedure ;
| - 3790. building design
- [ ] (UMLS (CSP) C0920686) =Occupational Activity
|
- 3741. BU/CTX/VP-16
- (UMLS (NCI) C0278706) =Therapeutic or Preventive Procedure
| - 3791. Building Location
- [The location of a building ( HL7V3.0 )] (UMLS (HL7) C1553438) =Intellectual Product =PlaceEntityType;
|
- 3742. BU/DHAD
- (UMLS (NCI) C0280742) =Therapeutic or Preventive Procedure
| - 3792. building number
- [The number of a building, house or lot alongside the street. Also known as "primary street number". This does not number the street but rather the building. ( HL7V3.0 )] (UMLS (HL7) C1550714) =Idea or Concept =street address line;
=building number numeric |
- 3743. BU/DM/TSPA
- (UMLS (NCI) C0338241) =Therapeutic or Preventive Procedure
| - 3793. building number numeric
- [The numeric portion of a building number ( HL7V3.0 )] (UMLS (HL7) C1555560) =Idea or Concept =building number;
|
- 3744. BU/IFN-A
- (UMLS (NCI) C0338169) =Therapeutic or Preventive Procedure
| - 3794. building number suffix
- [Any alphabetic character, fraction or other text that may appear after the numeric portion of a building number ( HL7V3.0 )] (UMLS (HL7) C1555561) =Idea or Concept =AddressPartType;
=post box;
|
- 3745. BU/L-PAM
- (UMLS (NCI) C0279844) =Therapeutic or Preventive Procedure
| - 3795. building renovation
- [ ] (UMLS (CSP) C0920408) =Occupational Activity
|
- 3746. BU/L-PAM/MePRDL
- (UMLS (NCI) C0678098) =Therapeutic or Preventive Procedure
| - 3796. building/facility design/renovation
- [ ] (UMLS (CSP) C0178524) =Occupational Activity ;
=biomedical facility;
|
- 3747. BU/L-PAM/TSPA
- (UMLS (NCI) C0281475) =Therapeutic or Preventive Procedure
| - 3797. Bulbar Conjunctiva
- [The part of the conjunctiva, a thin transparent mucous membrane, that is loosely attached the orbital septum and covers the anterior surface of the sclera. ( NCI )] (UMLS (NCI) C0229275) =Body Part, Organ, or Organ Component
|
- 3748. BU/TSPA
- (UMLS (NCI) C0281472) =Therapeutic or Preventive Procedure
| - 3798. Bulbourethral Gland
- [Glands situated on each side of the prostate that secrete a fluid component of the seminal fluid into the urethra. ( MSH )] (UMLS (NCI) C0006366) =Body Part, Organ, or Organ Component ;
|
- 3749. BU/VP-16
- (UMLS (NCI) C0281160) =Therapeutic or Preventive Procedure ;
| - 3799. Bulbus Cordis
- (UMLS (NCI) C1284055) =Embryonic Structure
|
- 3750. BUB1
- [This gene is a modulator of the mitotic spindle cell cycle checkpoint. ( NCI )] (UMLS (NCI) C1332455) BUB1 Budding Uninhibited by Benzimidazoles 1 Homolog Gene;
BUB1 Gene;
=Gene or Genome ;
◊ [BUB1 Budding Uninhibited by Benzimidazoles 1 Homolog (Yeast), encoded by the human BUB1 gene, is a 120-kD serine/threonine protein kinase. This protein monitors the attachment of chromosomes to spindle poles and may be a component of the mitotic checkpoint that delays anaphase until all chromosomes are properly attached to the mitotic spindle. As part of a common complex in checkpoint-activated cells, Bub1 monitors different spindle events compared to BubR1 and integrates different signals into a single signal that is then relayed to the downstream cell cycle machinery. It interacts with Bub3, CENP-F, CENP-E and mitosin. The BUB1 gene is highly expressed in thymus followed by spleen. Defects in Bub1 are associated with tumor formation. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C1332456) BUB1 Budding Uninhibited by Benzimidazoles 1 Homolog; BUB1 Budding Uninhibited by Benzimidazoles 1 Homolog (Yeast); Amino Acid, Peptide, or Protein; Enzyme | - 3800. Bulbus cordis anomalies and anomalies of cardiac septal closure
- [ ] (UMLS (ICD9CM) C0158606) =Congenital Abnormality ;
|
home
